We analyzed MCT1/4 expression in primary leukemic blast cells from AML patients and found that MCT1 and 4 mRNAs are overexpressed in most of AML patients, as compared to normal CD34+ HPCs (Figures 3A, B). This evidence concerns the gene SLC16A1 and acute myeloid leukemia.